Recap: Amryt Pharma Q3 Earnings

Amryt Pharma AMYT reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Amryt Pharma missed estimated earnings by 20.0%, reporting an EPS of $-0.06 versus an estimate of $-0.05.

Revenue was up $4.61 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 1.29% increase in the share price the next day.

Here's a look at Amryt Pharma's past performance:

To track all earnings releases for Amryt Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.